Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elliott, C.
Right arrow Articles by Kanfer, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, C.
Right arrow Articles by Kanfer, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 14, 970-973, Copyright © 1996 by American Society of Clinical Oncology


ARTICLES

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood

C Elliott, DM Samson, S Armitage, MP Lyttelton, D McGuigan, R Hargreaves, C Giles, G Abrahamson, Z Abboudi, M Brennan and EJ Kanfer
Charing Cross Hospital, London, United Kingdom.

PURPOSE: To evaluate whether the CD34+ yield from a single peripheral- blood stem-cell (PBSC) harvest could be predicted by measurement of the patient's circulating WBC and CD34+ cell concentrations on the day before harvest. PATIENTS AND METHODS: Thirty-nine patients with hematologic or nonhematologic malignancy underwent 41 stem-cell mobilization episodes with cytotoxic chemotherapy and/or granulocyte colony-stimulating factor (G-CSF), and a total of 63 leukapheresis procedures were performed. Peripheral-blood samples were analyzed for WBC and CD34+ cell concentration both on the day before and the day of leukapheresis. RESULTS: The median WBC and CD34+ concentrations on the day preceding leukapheresis were 10.0 x 10(9)/L (range, 0.4 to 44.4) and 24.9 x 10(6)/L (range, 0.1 to 349.4), respectively. On the day of harvest, the corresponding figures were 15.1 x 10(9)/L (range, 1.5 to 52.6) and 29.3 x 10(6)/L (range, 0.1 to 543.1), respectively. The median CD34+ cell number collected in a single leukapheresis was 2.6 x 10(6)/kg body weight (range, 0.1 to 26.1). Both the preceding day (r = .84, P < .001) and harvest day (r = .95, P < .001) CD34+ circulating concentrations correlated significantly with the number of CD34+ cells per kilogram collected at leukapheresis. The correlation between CD34+ cells per kilogram collected and harvest day WBC count was also significant (r = .43, P <.001), but with the preceding day WBC count was nonsignificant. CONCLUSION: The number of CD34+ cells harvested in a single leukapheresis can be predicted by measurement of the preceding day peripheral-blood circulating CD34+ concentration, and on the basis of these data a table of probable CD34+ cell yield has been constructed. This correlation may facilitate the efficient organization of leukapheresis procedures.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
D. H. Kim, H.-B. Leu, J.-W. Chen, S.-J. Lin, H. C. Ott, D. A. Taylor, F. Bertolini, P. Mancuso, R. S. Kerbel, C. J. Boos, et al.
Circulating Endothelial Progenitor Cells
N. Engl. J. Med., December 15, 2005; 353(24): 2613 - 2616.
[Full Text] [PDF]


Home page
JCOHome page
M. Engelhardt, H. Bertz, M. Afting, C. F. Waller, and J. Finke
High- Versus Standard-Dose Filgrastim (rhG-CSF) for Mobilization of Peripheral-Blood Progenitor Cells From Allogeneic Donors and CD34+ Immunoselection
J. Clin. Oncol., July 1, 1999; 17(7): 2160 - 2160.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Fukuda, T. Kaneko, M. Egashira, and K. Oshimi
Direct Measurement of CD34+ Blood Stem Cell Absolute Counts by Flow Cytometry
Stem Cells, July 1, 1998; 16(4): 294 - 300.
[Abstract] [Full Text]


Home page
BloodHome page
T. Teshima, K. Sunami, A. Bessho, K. Shinagawa, E. Omoto, H. Ueoka, M. Harada, Y. Ohno, T. Miyoshi, T. Miyamoto, et al.
Circulating Immature Cell Counts on the Harvest Day Predict the Yields of CD34+ Cells Collected After Granulocyte Colony-Stimulating Factor Plus Chemotherapy-Induced Mobilization of Peripheral Blood Stem Cell
Blood, June 15, 1997; 89(12): 4660 - 4660.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1996 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online